BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Lung Cancer Research Foundation - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Lung Cancer Research Foundation
X-ORIGINAL-URL:https://www.lungcancerresearchfoundation.org
X-WR-CALDESC:Events for Lung Cancer Research Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240305T170000
DTEND;TZID=America/New_York:20240305T183000
DTSTAMP:20260430T140411
CREATED:20240205T193927Z
LAST-MODIFIED:20240205T201141Z
UID:10000282-1709658000-1709663400@www.lungcancerresearchfoundation.org
SUMMARY:EGFR Resisters research update
DESCRIPTION:Join us for a virtual update with recipients of the 2022 LCRF and EGFR Resisters Research Grant on EGFR-Driven Lung Cancer! This informative webinar will allow participants an opportunity to hear from grantees and ask questions about their research projects. Please RSVP below and watch your email for the Zoom details. \n\n\n\nSpeakers\n\n\n\n\nSwarnali Acharyya\, PhDColumbia University Medical CenterResearch project:Drugging the S100A9-Retinoic acid pathway: companion biomarker and therapy \n\n\n\n\n\n\n\n\n\nLuke Hoeppner\, PhDUniversity of Minnesota\, Twin CitiesResearch project:Predictive biomarkers and new therapeutic strategies to prevent EGFR TKI-refractory lung cancer progression \n\n\n\n\n\n\n\n\n\nJonathan Ostrem\, MD\, PhDUniversity of California\, San FranciscoResearch project:Enhancing the precision of targeted therapies for EGFR-mutant lung cancer
URL:https://www.lungcancerresearchfoundation.org/event/egfr-resisters-research-update/
ATTACH;FMTTYPE=image/png:https://www.lungcancerresearchfoundation.org/wp-content/uploads/EGFR-LCRF-blog.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T150000
DTEND;TZID=America/New_York:20240313T163000
DTSTAMP:20260430T140411
CREATED:20231116T200840Z
LAST-MODIFIED:20240304T153410Z
UID:10000276-1710342000-1710347400@www.lungcancerresearchfoundation.org
SUMMARY:#TogetherSeparately: IASLC Targeted Therapies Recap
DESCRIPTION:In this live virtual meetup\, Stephen V. Liu\, MD\, Director of Thoracic Oncology and Head of Developmental Therapeutics\, Georgetown University\, will give an overview of the topics discussed during February’s IASLC Targeted Therapies Meeting. \n\n\n\nThe IASLC Targeted Therapies of Lung Cancer Meeting is a dynamic event with a long tradition. Presenters will summarize data on relevant targets for new therapies and share data on preclinical and early clinical trials for each of the drugs directed against these targets. \n\n\n\n\n\n\n\n\n\nDr. Stephen V. Liu\n\n\n\n\n\nDr. Isabel Preeshagul\n\n\n\n\n\n\n\n\n\nIsabel Preeshagul\, DO\, MBS\, will moderate. Dr. Preeshagul is a thoracic oncologist with Memorial Sloan Kettering Cancer Center. \n\n\n\nThis livestream is an opportunity to connect face-to-face with others who care about lung cancer and talk about challenges we’re facing\, #TogetherSeparately. Please register below for this free event. Your confirmation email will include login details. \n\n\n\n\n\n\n\n\n\n\n\nRegistration form
URL:https://www.lungcancerresearchfoundation.org/event/togetherseparately-iaslc-targeted-therapies-recap/
CATEGORIES:Education
ATTACH;FMTTYPE=image/jpeg:https://www.lungcancerresearchfoundation.org/wp-content/uploads/TogetherSeparately-banner-1.jpg
END:VEVENT
END:VCALENDAR